Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis-Reference-Cited by-同舟云学术

Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis

Published:2022-10-13 Issue:1 Volume:23 Page:8-13
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Antonatos Charalabos^ORCID,Patsatsi Aikaterini,Zafiriou Efterpi,Stavrou Eleana F.,Liaropoulos Andreas^ORCID,Kyriakoy Aikaterini,Evangelou Evangelos,Digka Danai,Roussaki-Schulze Angeliki,Sotiriadis Dimitris,Georgiou Sophia,Grafanaki Katerina^ORCID,Moschonas Nicholas Κ.^ORCID,Vasilopoulos Yiannis^ORCID

Funder

Infrastructure for preclinical and early-phase clinical development of drugs, therapeutics and biomedical devices (EATRIS-GR)

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/s41397-022-00291-7.pdf

Reference28 articles.

1. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Investigative Dermatol. 2013;133:377–85.

2. Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C, Larios G, Stamou C, et al. Characteristics of psoriasis in Greece: An epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol. 2010;20:189–95.

3. Mylonas A, Conrad C. Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and type I Interferon. Front Immunol. 2018;9:2746.